Rosalind Advisors’s MediWound MDWD Stock Holding History

Rosalind Advisors’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11M	Hold	749,054	–	–	4.09%	11
2026 Q1	$12.1M	Hold	749,054	–	–	4.85%	9
2025 Q4	$13.8M	Hold	749,054	–	–	4.86%	6
2025 Q3	$13.5M	Buy	749,054 +341,993	+84%	+$6.31M	4.61%	8
2025 Q2	$7.88M	Sell	407,061 -99,832	-20%	-$1.88M	3.74%	11
2025 Q1	$7.87M	Sell	506,893 -121,157	-19%	-$2.17M	3.83%	12
2024 Q4	$11.2M	Hold	628,050	–	–	5.72%	3
2024 Q3	$11.3M	Buy	628,050 +114,560	+22%	+$2.09M	7.26%	5
2024 Q2	$7.97M	Buy	513,490 +27,500	+6%	+$455K	6.13%	3
2024 Q1	$6.93M	Sell	485,990 -120,761	-20%	-$1.65M	6.47%	3
2023 Q4	$6.17M	Buy	+606,751	New	+$5.45M	5.08%	8

Other funds holding MDWD

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Rosalind Advisors's MDWD Position: Q2 2026 in Review

Rosalind Advisors held its MediWound (MDWD) position steady in Q2 2026 at 749,054 shares worth $11M. The position accounts for 4.09% of the portfolio, ranked #11.

Rosalind Advisors first reported a position in MDWD in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.8M in Q4 2025. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

Rosalind Advisors held 749,054 shares of MediWound worth $11M as of Q2 2026.
Rosalind Advisors left its MediWound share count unchanged in Q2 2026.
MediWound made up 4.09% of Rosalind Advisors's portfolio in Q2 2026, its #11 holding.
Rosalind Advisors first reported a position in MediWound in Q4 2023 and has held it in 11 quarters since.
Rosalind Advisors's MediWound position peaked at $13.8M in Q4 2025.
79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on Rosalind Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.